Autolus Therapeutics plc (AUTL) › Shareholders' EquityAutolus Therapeutics plc (AUTL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: $10.50M2016: $30.69M2017: $142.60M2018: $232.64M2019: $254.84M2020: $210.03M2021: $313.32M2022: $298.67M2023: $111.47M2024: $427.32M2025: $178.13M$178.13M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$178.13M-58.3%2024$427.32M+283.3%2023$111.47M-62.7%2022$298.67M-4.7%2021$313.32M+49.2%2020$210.03M-17.6%2019$254.84M+9.5%2018$232.64M+63.1%2017$142.60M+364.7%2016$30.69M+192.2%2015$10.50M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share